EMEA-000183-PIP02-12-M05 - paediatric investigation plan
apixaban
PIPHuman
Key facts
- Invented name
- Eliquis
- Active substance
- apixaban
- Therapeutic area
- Cardiovascular diseases
- Decision number
- P/0135/2024
- PIP number
- EMEA-000183-PIP02-12-M05
- Pharmaceutical form(s)
- Film-coated tablet
- Age appropriate oral liquid dosage formulation
- Age appropriate dosage form, other
- Condition(s) / indication(s)
- Treatment of venous thromboembolism
- Route(s) of administration
- Oral use
- Contact for public enquiries
Bristol-Myers Squibb Pharma EEIG
Email: medical.information@bms.com
Tel. +44 1895523740- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date